Extrapulmonary manifestations of chronic obstructive pulmonary disease in a mouse model of chronic cigarette smoke exposure

American Journal of Respiratory Cell and Molecular Biology

Volumn 40, Issue 6, 2009, Pages 710-716

  Gosker, Harry R ^a,d   Langen, Ramon C J ^a   Bracke, Ken R ^b   Joos, Guy F ^b   Brusselle, Guy G ^b   Steele, Chad ^c   Ward, Kimberly A ^a   Wouters, Emiel F M ^a   Schols, Annemie M W J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease; Cigarette smoking; Murine model; Skeletal muscles; Systemic inflammation

Indexed keywords

CHEMOKINE; CIGARETTE SMOKE; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; EMPHYSEMA; ENZYME ACTIVITY; GASTROCNEMIUS MUSCLE; INFLAMMATION; LUNG LAVAGE; MOUSE; MUSCLE CELL; MUSCLE MASS; NONHUMAN; PATHOGENESIS; PLANTARIS MUSCLE; PROTEIN ANALYSIS; SKELETAL MUSCLE; SOLEUS MUSCLE;

ANIMALS; BRONCHOALVEOLAR LAVAGE; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MYOSIN HEAVY CHAINS; PROTEIN ISOFORMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SMOKE; SMOKING;

MURINAE; MUS;

EID: 66349105300     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0312OC     Document Type: Article

References (34)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-555. (Pubitemid 47403272)
2. Fabbri LM, Pauwels RA, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary updated 2003. COPD 2004;1:105-141.
3. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest 2007;131:1557-1566. (Pubitemid 46762366)
4. ATS/ERS. Skeletal muscle dysfunction in chronic obstructive pulmonary disease: a statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999;159:S1-S40. (Pubitemid 29181385)
5. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-580. (Pubitemid 38901515)
6. Gosker HR, Engelen MPKJ, van Mameren H, van Dijk PJ, van der Vusse GJ, Wouters EFM, Schols AMWJ. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002;76:113-119. (Pubitemid 34686556)
7. Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, Bernard S, Belleau R, Maltais F. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 1998;30:1467-1474. (Pubitemid 28465510)
8. Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fibre types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J 1990;3:192-196. (Pubitemid 20066922)
9. Gosker HR, van Mameren H, van Dijk PJ, Engelen MPKJ, van der Vusse GJ, Wouters EFM, Schols AMWJ. Skeletal muscle fibre type shifting and metabolic profile in patients with COPD. Eur Respir J 2002;19:617-626.
10. Jakobsson P, Jorfeldt L, Henriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;151:374-377.
11. Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996;153:288-293. (Pubitemid 26026864)
12. Larsson L, Orlander J. Skeletal muscle morphology, metabolism and function in smokers and non-smokers: a study on smoking-discordant monozygous twins. Acta Physiol Scand 1984;120:343-352. (Pubitemid 14162600)
13. D'Hulst AI, Vermaelen KY, Brusselle GG, Joos GF, Pauwels RA. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J 2005;26:204-213. (Pubitemid 41079063)
14. Zeid NA, Muller HK. Tobacco smoke induced lung granulomas and tumors: association with pulmonary Langerhans cells. Pathology 1995;27:247-254.
15. Bracke KR, D'Hulst AI, Maes T, Moerloose KB, Demedts IK, Lebecque S, Joos GF, Brusselle GG. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J Immunol 2006;177:4350-4359. (Pubitemid 44469763)
16. Ling KH, Pastkau V, Marcus F, Lardy HA. Phosphofructokinase. I. Skeletal muscle. Methods Enzymol 1966;9:425-429.
17. Bergmeyer HU, Gawehn K, Grassl M. 3-Hydroxyacyl-CoA dehydrogenase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. Weinheim: Verlag Chemie GmbH; 1974. p. 474.
18. Shephard D, Garland PB. Citrate synthase from rat liver. Methods Enzymol 1969;13:11-16.
19. Gohil K, Jones D, Edwards R. Analysis of muscle mitochondrial function with techniques applicable to needle biopsy samples. Clin Physiol 1981;1:195-207. (Pubitemid 11059094)
20. Schreiber WE, Bowling S. An automated assay of glycogen phosphorylase in the direction of phosphorolysis. Ann Clin Biochem 1990;27:129-132. (Pubitemid 20086514)
21. Talmadge RJ, Roy RR. Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol 1993;75:2337-2340. (Pubitemid 23352414)
22. Ardite E, Peinado VI, Rabinovich RA, Fernandez-Checa JC, Roca J, Barbera JA. Systemic effects of cigarette smoke exposure in the guinea pig. Respir Med 2006;100:1186-1194. (Pubitemid 44207849)
23. Petersen AM, Magkos F, Atherton P, Selby A, Smith K, Rennie MJ, Pedersen BK, Mittendorfer B. Smoking impairs muscle protein synthesis and increases the expression of myostatin and MAFbx in muscle. Am J Physiol Endocrinol Metab 2007;293:E843-E848. (Pubitemid 47358998)
24. Orlander J, Kiessling KH, Larsson L. Skeletal muscle metabolism, morphology and function in sedentary smokers and nonsmokers. Acta Physiol Scand 1979;107:39-46. (Pubitemid 10193745)
25. Wust RC, Morse CI, de Haan A, Rittweger J, Jones DA, Degens H. Skeletal muscle properties and fatigue resistance in relation to smoking history. Eur J Appl Physiol 2008;104:103-110.
26. Montes de Oca M, Loeb E, Torres SH, De Sanctis J, Hernandez N, Talamo C. Peripheral muscle alterations in non-COPD smokers. Chest 2008;133:13-18.
27. Nakatani T, Nakashima T, Kita T, Ishihara A. Effects of exposure to cigarette smoke at different dose levels on extensor digitorum longus muscle fibres in Wistar-Kyoto and spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2003;30:671-677. (Pubitemid 37222745)
28. Nakatani T, Nakashima T, Kita T, Ishihara A. Responses of exposure to cigarette smoke at three dosage levels on soleus muscle fibers in Wistar-Kyoto and spontaneously hypertensive rats. Jpn J Pharmacol 2002;90:157-163. (Pubitemid 35291302)
29. Gosker HR, Zeegers MP, Wouters EF, Schols AM. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 2007;62:944-949. (Pubitemid 350084491)
30. Guerassimov A, Hoshino Y, Takubo Y, Turcotte A, Yamamoto M, Ghezzo H, Triantafillopoulos A, Whittaker K, Hoidal JR, Cosio MG. The development of emphysema in cigarette smoke-exposed mice is strain dependent. Am J Respir Crit Care Med 2004;170:974-980. (Pubitemid 39425693)
31. Mattson JP, Poole DC. Pulmonary emphysema decreases hamster skeletal muscle oxidative enzyme capacity. J Appl Physiol 1998;85:210-214. (Pubitemid 28334927)
32. Langen RC, Schols AM, Kelders MC, van der Velden JL, Wouters EF, Janssen-Heininger YM. Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation. Am J Respir Cell Mol Biol 2006;35:689-696. (Pubitemid 44901858)
33. D'Hulst AI, Bracke KR, Maes T, De Bleecker JL, Pauwels RA, Joos GF, Brusselle GG. Role of tumour necrosis factor-alpha receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema. Eur Respir J 2006;28:102-112. (Pubitemid 44914267)
34. De Paepe B, Brusselle GG, Maes T, Creus KK, D'Hose S, D'Haese N, Bracke KR, D'Hulst AI, Joos GF, De Bleecker JL. TNFalpha receptor genotype influences smoking-induced muscle-fibre-type shift and atrophy in mice. Acta Neuropathol 2008;115:675-681.